LL/2 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF837
Target Cell Organism: Mouse
Target Cell Alternative Name: LLC1
Target Cell Name: LL/2
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide LL/2-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LL/2
Target Cell Organism
Mouse
Target Cell Background
LL/2 (LLC1) is a cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma.
Target Cell Alternative Name
LLC1
Related Diseases
Lewis Lung Carcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
LL/2-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry